Numinus builds on strong MAPS Phase 3 trial results through Compassionate Access Trial of MDMA for PTSD

[embed][/embed] Yesterday, MAPS announced significant, positive results

Read More
Interior of a forest with dense trees and large rocks

Numinus Congratulates MAPS on Phase 3 Clinical Trial of MDMA for severe PTSD

[embed][/embed] 1 in 11 Canadians will suffer from PTS

Read More

Numinus Wellness’s trial for MDMA-assisted therapy is in pre-implementation stage

The study, which is in collaboration with MAPS Public Benefit Corporation (MAPS PBC), subsidiary of

Read More

Numinus Wellness Acquires Mindspace Wellbeing to Expand into Montreal

Numinus Wellness Inc. will soon have three locations in Montreal thanks to a recent acquisition.

Read More

Company with Nanaimo lab gets federal approval for psychedelic drug research

Numinus' recently amended Health Canada licence allows the company to produce and extract psilocybin

Read More

We want to connect with you!

Sign up here so we can keep in touch.